A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma
โ Scribed by Jonathan C. Yau; Ywee-Yong Yap; Aman U. Buzdar; Gabriel N. Hortobagyi; Gerald P. Bodey; George R. Blumenschein
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 377 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective
## Background: The high rate of incidence of skeletal complications in women with metastatic breast carcinoma appears to contribute significantly to their morbidity. although recent trials have demonstrated the efficacy of bisphosphonates in preventing skeletal complications in selected patients, t
## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act